chr22-43963335-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015380.5(SAMM50):āc.71A>Gā(p.Glu24Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000325 in 1,613,288 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015380.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SAMM50 | NM_015380.5 | c.71A>G | p.Glu24Gly | missense_variant | 2/15 | ENST00000350028.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SAMM50 | ENST00000350028.5 | c.71A>G | p.Glu24Gly | missense_variant | 2/15 | 1 | NM_015380.5 | P1 | |
PNPLA3 | ENST00000406117.6 | c.*899A>G | 3_prime_UTR_variant, NMD_transcript_variant | 9/10 | 2 | ||||
SAMM50 | ENST00000493161.1 | n.314+109A>G | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152160Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000279 AC: 70AN: 250644Hom.: 0 AF XY: 0.000325 AC XY: 44AN XY: 135514
GnomAD4 exome AF: 0.000346 AC: 505AN: 1461128Hom.: 0 Cov.: 29 AF XY: 0.000338 AC XY: 246AN XY: 726890
GnomAD4 genome AF: 0.000125 AC: 19AN: 152160Hom.: 0 Cov.: 31 AF XY: 0.0000807 AC XY: 6AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2023 | The c.71A>G (p.E24G) alteration is located in exon 2 (coding exon 2) of the SAMM50 gene. This alteration results from a A to G substitution at nucleotide position 71, causing the glutamic acid (E) at amino acid position 24 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at